Centropneus Recalls Michelin CrossClimate 2 Tires for Missing DOT Markings
Centropneus is recalling 640 Michelin CrossClimate 2 tires because they are missing the required DOT certification symbol on the sidewalls.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall involves a labeling defect (missing DOT symbol) that creates a theoretical risk of inappropriate use and crash, but no injuries or deaths are reported, fitting the Moderate criteria for low-risk contamination or labeling errors.
Plain-English summary
Centropneus SRL is recalling 640 Michelin CrossClimate 2 tires, size 255/60R18 112V XL. The recall is due to the missing DOT certification symbol on the tire sidewalls, which means the tires do not comply with Federal Motor Vehicle Safety Standard number 139, "New Pneumatic Radial Tires for Light Vehicles."
The missing DOT symbol may allow the tires to be used in inappropriate applications, which increases the risk of a crash. No specific vehicles are listed in the affected vehicles data, but the tires are subject to replacement.
Dealers will replace the affected tires free of charge. Owner notification letters were mailed on August 5, 2025. Owners can contact Centropneus customer service at 1-800-933-2537 for more information.
The recalled product
- Product
- TIRES:MARKINGS recall
- Manufacturer
- Centropneus SRL
- Category
- Vehicle — Tires
- Hazard
- Affected units
- 640
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02